Biohaven Stock Crashes After Protein-Degrading Drug Misses Expectations
Biohaven stock crashed Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
Source: investors.com
Stay updated with breaking news from Tim Lugo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biohaven stock crashed Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
SRPT earnings call for the period ending December 31, 2023.
Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.
William Blair analyst Tim Lugo has maintained their bullish stance on CRSP stock, giving a Buy rating on February 15. Tim Lugo has given his Bu...